TAF1 SPLICING VARIANTS AND PROLYL HYDROXYLASE INHIBITORS IN HUNTINGTON’S DISEASE

• Claudia Rodríguez-López,
• Ivó Hernández Hernández,
• María González-Bermejo,
• Marcos Casado Barbero,
• José Lucas

Affiliations

Claudia Rodríguez-López

Center for Molecular Biology Severo Ochoa, Neuropathology, Madrid, Spain

Ivó Hernández Hernández

Spanish National Cancer Research Center (CNIO), Genomic Inestability, Madrid, Spain

María González-Bermejo

Center for Molecular Biology Severo Ochoa, Neuropathology, Madrid, Spain

Marcos Casado Barbero

European Bioinformatics Institute (EMBL-EBI), Metadata, Cambridge, United Kingdom

José Lucas

Center for Molecular Biology Biology “Severo Ochoa” (CBMSO) CSIC/UAM, Molecular Neuropathology, Madrid, Spain